文献速递骨肌CT

多发性骨髓瘤与溶骨性骨转移的鉴别:增强CT上肿瘤均匀性的诊断价值

Differentiation of multiple myelomas from osteolytic bone metastases: Diagnostic value of tumor homogeneity on Contrast-Enhanced CT.
PubMed 文献 · Br J Radiol · 2022-07-21

本回顾性研究纳入105例患者共272个溶骨性骨肿瘤病灶,评估增强CT上病灶内和病灶间密度均匀性(以变异系数CV表示)对鉴别多发性骨髓瘤(MM)与骨转移瘤(Mets)的价值。MM的CV-lesion和CV-patient均显著低于Mets(0.17 vs 0.26,p=0.005;0.16 vs 0.23,p=0.013),粗骨小梁在MM中更常见(49.1% vs 12.8%,p≤0.001)。基于CART模型联合CV-lesion、粗骨小梁和CV-patient可区分MM与Mets,模型开发队列C-statistic为0.843,时间验证队列三位阅片者分别为0.721、0.686和0.686。

要点

  • MM病灶内密度均匀性高于Mets:CV-lesion 0.17 vs 0.26(p=0.005)。
  • MM病灶间密度均匀性高于Mets:CV-patient 0.16 vs 0.23(p=0.013)。
  • 粗骨小梁在MM中更常见:49.1% vs 12.8%(p≤0.001)。

核心结论

  • 增强CT上MM较Mets表现为病灶内和病灶间密度更均匀,联合CV-lesion与CV-patient有助于放射科医生鉴别MM与Mets。

研究设计与样本

  • 回顾性研究,纳入105例患者共272个溶骨性骨肿瘤病灶(MM 81个,Mets 191个),分析治疗前增强CT。

关键影像表现/征象

  • MM的病灶内密度变异系数(CV-lesion)为0.17,低于Mets的0.26(p=0.005)。
  • MM的病灶间密度变异系数(CV-patient)为0.16,低于Mets的0.23(p=0.013)。
  • 粗骨小梁在MM中占49.1%,在Mets中占12.8%(p≤0.001)。

诊断标准与关键数值

  • CART模型中CV-lesion为首个分割预测因子,其次为粗骨小梁和CV-patient。
  • CART模型在模型开发队列的C-statistic为0.843。
  • CART模型在时间验证队列三位阅片者的C-statistic分别为0.721、0.686和0.686。

临床应用与阅片要点

  • 作者认为联合CV-lesion与CV-patient可帮助放射科医生鉴别MM与Mets。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the diagnostic value of tumor homogeneity on contrast-enhanced (CE) computed tomography (CT) to differentiate multiple myeloma (MM) from osteolytic bone metastases (Mets).

METHODS: This retrospective study included patients who were diagnosed with MM or Mets and had multiple (≥2) osteolytic bone tumors on pre-treatment CE-CT. Intratumoral homogeneity was assessed by coefficient of variation (CV, ratio of standard deviation to mean) of the density of a single lesion (CV-lesion). Intertumoral homogeneity was assessed as the CV of the densities of multiple lesions in one patient (CV-patient). A classification model was built from CT parameters using classification and regression tree (CART) analysis. Diagnostic performance of the model was evaluated using C-statistics.

RESULTS: A total of 272 lesions (81 MM and 191 Mets) of 105 patients were analyzed. The mean CV-lesion and CV-patient of MM were significantly lower than those of Mets: 0.17 vs 0.26 for CV-lesion (p = 0.005) and 0.16 vs 0.23 for CV-patient (p = 0.013). Thickened struts were more common in MM than in Mets (49.1% vs 12.8%, p ≤ 0.001). In CART analysis, CV-lesion was the first partitioning predictor, followed by thickened struts and by CV patient. The CART model could distinguish MM from Mets in both the model development cohort (C-statistic: 0.843) and the temporal validation cohort (0.721, 0.686, and 0.686 for three reviewers, respectively).

CONCLUSIONS: MM showed intratumoral and intertumoral homogeneity compared with Mets on CE-CT. The combination of CV-lesion and CV-patient can be helpful to radiologists in differentiation of MM from Mets.

ADVANCES IN KNOWLEDGE: Our study showed that MM had intratumoral and intertumoral homogeneity compared with Mets on contrast-enhanced CT.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Huh, Lee, Kim, et al. Differentiation of multiple myelomas from osteolytic bone metastases: Diagnostic value of tumor homogeneity on Contrast-Enhanced CT. Br J Radiol. 2022. PMID: 35819897. doi:10.1259/bjr.20220009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。